Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population-Reference-Cited by-同舟云学术

Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population

Published:2023-03 Issue:3 Volume:81 Page:294-306.e1
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Yu Xueqing,Chen Nan,Xue Jun,Mok Chi Chiu,Bae Sang-Cheol,Peng Xiaomei,Chen Wei,Ren Hong,Li Xiao,Noppakun Kajohnsak,Gilbride Jennifer A.,Green Yulia,Ji Beulah,Liu Chang,Madan Anuradha,Okily Mohamed,Tang Chun-Hang,Roth David A.

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Nephrology

Reference25 articles.

1. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort;Urowitz;Arthritis Care Res (Hoboken),2012

2. The frequency and outcome of lupus nephritis: results from an international inception cohort study;Hanly;Rheumatology (Oxford),2016

3. Baseline characteristics of a multiethnic lupus cohort: PROFILE;Alarcon;Lupus,2002

4. Characterization of patients with lupus nephritis included in a large cohort from the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER);Galindo-Izquierdo;Medicine (Baltimore),2016

5. Lupus nephritis: current treatment paradigm and unmet needs;Menez;Rev Recent Clin Trials,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS;Kidney International;2024-01

2. Efficacy of Telitacicept in a systemic lupus erythematosus patient with suboptimal response to Belimumab: A case report;Lupus;2023-12-11

3. Advances in the treatment of IgA nephropathy with biological agents;Chronic Diseases and Translational Medicine;2023-12-10

4. Biomarkers Associated with Drugs for the Treatment of Lupus Nephritis;Biomolecules;2023-10-31

5. B cell metabolism in autoimmune diseases: signaling pathways and interventions;Frontiers in Immunology;2023-08-23